Status:
COMPLETED
Contralateral Study of WaveLight® Femtosecond Laser Devices for Corneal Flap Creation
Lead Sponsor:
Alcon Research
Conditions:
Refractive Errors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the WaveLight Ultraviolet Femtosecond Laser System, Model 1026 (UV fs-Laser) corneal flap creation accuracy as compared to the already marketed WaveLight FS200 I...
Detailed Description
Subjects who qualify to participate will have both eyes treated in the study (one eye with the UV fs-Laser and the other eye with the IR fs-Laser) and will attend a total of 5 study visits over a peri...
Eligibility Criteria
Inclusion
- Key
- Good ocular health;
- Natural lens with no evidence of cataract;
- Eligible for LASIK;
- Stable refraction;
- Other protocol-defined inclusion criteria may apply.
- Key
Exclusion
- Presence of dry eye;
- Contraindicated systemic disease or ocular conditions;
- Treatment with a contraindicated medication;
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
October 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 12 2024
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT06021353
Start Date
October 20 2023
End Date
December 12 2024
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Personaleyes
Sydney, New South Wales, Australia, 2000